LEADER 01567nam  2200385 a 450 
001 9910697853703321
005 20081209141057.0
035   $a(CKB)5470000002392446
035   $a(OCoLC)277233441
035   $a(EXLCZ)995470000002392446
100   $a20081209d2008      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aDrug safety$b[electronic resource] $ebetter data management and more inspections are needed to strengthen FDA's foreign drug inspection program : report to congressional requesters
210  1$a[Washington, D.C.] :$cU.S. Govt. Accountability Office,$d[2008]
215   $aii, 53 pages $cdigital, PDF file
300   $aTitle from title screen (viewed on Nov. 20, 2008).
300   $a"September 2008."
300   $a"GAO-08-970."
320   $aIncludes bibliographical references.
330   $aThis report examines (1) the extent to which FDA has accurate data on the number of foreign establishments subject to inspection, (2) the frequency of foreign inspections, and (3) oversight by FDA to ensure that foreign establishments correct serious problems identified during inspections.
517   $aDrug safety 
606   $aDrugs$xSafety measures
606   $aPharmaceutical industry$zForeign countries
615  0$aDrugs$xSafety measures.
615  0$aPharmaceutical industry
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910697853703321
996   $aDrug safety$92379886
997   $aUNINA